Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Nordic IBD Study Within Personalized Medicine - Diagnosing and Prediction Using Molecular Characterization of Inflammatory Bowel Disease: the NORDTREAT Prospective Cohort Study

NCT05414578 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.

NCT NCT05414578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05414578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Nordic IBD Study Within Personalized Medicine - Diagnosing and Prediction Using Molecular Characterization of Inflammatory Bowel Disease: the NORDTREAT Prospective Cohort Study
Lead sponsor
University of Southern Denmark
Phase
Observational
Overall status
Completed
Start date
February 7, 2022
Completion date
February 28, 2025
Enrollment
366 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), inflammatory bowel diseases (ibd), ulcerative colitis (uc)